Publication: Zilovertamab Vedotin in Combination With Nemtabrutinib for Patients With Relapsed or Refractory Mantle Cell Lymphoma: Cohort C of the Open-Label, Phase 2 Waveline-006 Study
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
WoS Q
Q1
Scopus Q
Q1
Source
Blood
Volume
144
Issue
Start Page
3025
End Page
3026